Congo launched its Ebola vaccination campaign in Kisangani on Thursday to combat the nation’s worst recorded epidemic, which has recorded 5,713 confirmed cases and 2,744 deaths.
The World Health Organization has recommended prioritizing the licensed Ebola vaccine Ervebo for a Phase 3 clinical trial in the Democratic Republic of the Congo. This decision follows emerging evidence of cross-protection against the fast-spreading Bundibugyo virus, as the outbreak surges past 4,000 cases and 1,800 deaths. An Unprecedented Outbreak Demands Immediate Intervention The current … Read more
We use cookies to run this site, measure traffic and — with your consent — to personalize ads. See our Cookie Policy.